SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?


To: FatMatty who wrote (2315)7/1/1998 2:22:00 PM
From: Mr. Forthright  Read Replies (1) | Respond to of 5402
 
<<Everyone here understands the risk...and (I assume to some degree) that hype will exist on every 'thread forum' where people converge to gather and disseminate ideas.>>

That is my point, not everyone understands the risks. I have read so much nonsense on these threads I just shake my head. I also receive a ton of Private Messages from small investors thanking me for presenting a different point of view. Fat Matty, also remember that for each person posting here there are several lurking.

My sole purpose here is to track down unscrupulous promoters who hype stocks. SGNC seems different. It appears to be legitimate but unfortunately the Rocketeers have hyped it and affected its credibility with investors. I am trying to rectify that by proposing a valuation model that we can all work on together. That is my contribution but all you guys are turning down my offer. Why? Don't you all what to go bed at night saying, based on a standard biotech valuation model my stock should trade at $XXXX as opposed to, according to macker, rocketeer1 and JimB the stock is going higher and the potential is huge, even bigger if the MM get squezzed?

Does this post answer some of your questions?



To: FatMatty who wrote (2315)7/1/1998 2:35:00 PM
From: Mr. Forthright  Read Replies (2) | Respond to of 5402
 
The first two questions for the valuation model were:

1) What is the total market potential for synthetic red blood cell products?

2) What kind of market share/penetration is SGNC expected to achieve?

Question number 3 is:

When is SGNC's product expected to get to market?

Let's get some answers now guys.